Trader Loracle averaged down ZEC long positions through forced liquidation, becoming the largest ZEC whale with a position size of $10.8 million.
BlockBeats news, on June 5, according to Hyperinsight monitoring, during the sharp drop of ZEC, well-known Hyperliquid trader Loracle saw continual increases in floating losses on his long positions. In the face of the decline, this address continued to roll over positions and inject large amounts of funds against the trend, taking longs down to around $250 at the lowest, reducing the average opening price from above $500 to $354.
After this dilution, his position size was pushed up to $10.8 million, with a total long of 34,800 ZEC, passively becoming the largest ZEC long holder on the Hyperliquid platform. As of press time, the floating loss on this position has reached $1.6 million (-130%) and is still being increased.
In addition, this address currently holds long positions in several tokens including HYPE, ZEC, and WLD, with total long positions amounting to $34.6 million and floating losses of $4 million.
Address: 0x8def9f50456c6c4e37fa5d3d57f108ed23992dae
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Third largest since 2008! US stocks saw single-week outflows of $11 billions, technology stocks hit hardest
Last week, institutional investors significantly sold off individual stocks, resulting in a net outflow of $11.0 billion from the U.S. stock market. Funds were mainly withdrawn from the technology sector, marking the third largest single-week outflow from individual stocks in the history of Bank of America's statistics.
Google (GOOGL.US) AI pharmaceutical company Isomorphic Labs launches new financing: Raised $2.1 billions five months ago, current round aims for a $50 billions valuation
Isomorphic Labs, a DeepMind spin-off, is in talks for new financing, with its valuation potentially reaching up to $50 billions. This comes only five months after its $2.1 billions Series B funding round.
Valuation hits a ten-year low! Barclays initiates coverage on 26 US medical technology stocks, with Stryker (SYK.US) among its top picks
Barclays analyst Christopher Pasquale on Tuesday initiated coverage on 26 US-listed medtech companies for the first time, and included Stryker (SYK.US) and Abbott (ABT.US) on the recommended list of large-cap medtech stocks.
Citigroup raises profit forecast; Australian exchange operator's stock price rises
On Thursday, shares of Australian Securities Exchange operator ASX Ltd (ASX.AX) surged to nearly a two-month high after Citi raised its annual profit outlook for the company, citing a strong first-quarter performance and predicting robust market activity to continue into the first half of the year. Details are as follows: The exchange operator's average daily trading volume in the spot market rose 16% year-on-year in September. Citi analysts noted that daily futures trading volumes climbed 44% during the month, approaching historical highs, possibly reflecting structural and cyclical factors, including interest rate prospects and changes in the bond market. Citi added that strong market activity is expected to last at least through the first half, and consequently raised ASX's annual earnings-per-share forecast by 2%. Citi pointed out, however, that corporate market activity remained subdued in September. Short-term market activity is expected to be boosted with Glencore's GLEN.L company planning a secondary listing in October and Firmus company planning an initial public offering (IPO) in October. Both Citi and UBS raised their target price for ASX from AU$60.10 and AU$64.20 to AU$61.00 and AU$65.50, respectively. Meanwhile, Goldman Sachs remains cautious about the strategy of the new CEO, Anthony Attia, and the company's potential future financial situation. Goldman Sachs is also alert to execution risks in the exchange operator's CHESS system replacement and technology modernization plans. This comes after the central bank stated in September that the company's clearing and settlement facilities had not met the bank's expectations. ASX shares closed up 3.8%, reaching their highest level in nearly two months and ranking among the top performers on the S&P/ASX 200 index.
Crypto prices
More
